Pyrantel Pamoate
 |
|
|
Chemical
Name |
1,4,5,6
– Tetrahydro-1-methyl-2-[{E}-2-(2-thienyl} vinyl) pyrimidine 4,4’-methylenebis
{3-hydroxy-2-naphthoate) |
|
Molecular
Formula |
C11H14N2S,C23H16O6 |
|
Molecular
Weight |
594.7 |
|
CAS
No. |
22204-24-6 |
|
Therapeutic
Category |
|
|
SPECIFICATIONS: |
|
|
Description |
Yellow
to tan solid |
|
Solubility |
Conforms
as per USP |
|
Identification |
By
I.R., UV & HPLC |
|
Related
Compounds A&B |
Conforms
by TLC as per USP |
|
Loss
On Drying |
NMT
2.0% |
|
Residue
On Ignition |
NMT
0.5% |
|
Heavy
Metals |
NMT
0.005% |
|
Iron |
NMT
0.0075% |
|
Pamoic
Acid Content |
63.4%
to 67.3% |
|
Assay
|
97.0 to 103.0%
on dried basis |
|
Packing |
25
/ 50 Kgs Drums |
| Patents : “Products covered by valid patents are not offered or supplied for commercial sale. The patents’s position should be verified by the customer” | |
| Albendazole
Sulphoxide | Albendazole | Nitroxynil
| Bithionol | Closantel
| Closantel sodium | |Fenbendazole
| febantel |Ivermectin
| Mebendazole | Morantel Citrate
| Niclosamide |Oxfendazole
| |Oxibendazole
| Oxyclozanide | Rafoxanide
|Toldimphos
Sodium | Triclabendazole|
| Pyrantel Pamoate |